StockData
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF

Radiopharm Theranostics Ltd

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026
$0.96−0.07 (-6.50%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Radiopharm Theranostics Ltd revenue by segment

No segment breakdown reported

Radiopharm Theranostics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.